Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

JAK inhibitors show promise for treating various skin diseases.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Tinea capitis in older adults is often misdiagnosed but can be effectively treated with antifungal therapy.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

A 13-year-old boy with a rare scalp condition improved significantly with isotretinoin, minoxidil, oral steroids, and antiseptic shampoo.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

A rare hair regrowth pattern can occur in some people with alopecia areata.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

ASC-CM is more effective than EV for treating osteoarthritis.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

PRP therapy can temporarily grow hair in CCCA patients but isn't a permanent cure.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Accurate diagnosis is crucial for effective treatment of similar hair loss conditions.

Effective immunomodulatory treatments and a personalized approach are crucial for managing severe folliculitis decalvans.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Dupilumab and COVID-19 can worsen or trigger psoriasis.